YOHOF News Alert Yoho Res Inc (YOHOF) 1.9200 10/01/2014 00:2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Yoho Res Inc (YOHOF) 1.9200 $YOHOF

Yoho Resources Inc. Announces Fiscal Q3 2014 Financial Results
Marketwire - Wed Aug 27, 3:31PM CDT
Yoho Resources Inc. ("Yoho" or the "Company" (TSX VENTURE: YO) has filed today on SEDAR the financial statements for the three and nine months ended June 30, 2014 and the related managements' discussion and analysis ("MD&A" . Copies of these documents may be found on www.sedar.com.

Yoho Resources Inc. Announces Successful Duvernay Drilling at Kaybob, Alberta
Marketwire - Wed Jul 09, 3:01PM CDT
Yoho Resources Inc. ("Yoho" or the "Company" (TSX VENTURE: YO) is pleased to provide an update of Duvernay drilling and completion operations at Kaybob, Alberta.

Yoho Announces Disposition of Common Shares of Storm Resources
Marketwire - Fri Mar 21, 10:25AM CDT
Yoho Resources Inc. ("Yoho" or the "Company" (TSX VENTURE: YO) announces that as a result of a plan of arrangement (the "Arrangement" completed pursuant to the provisions of the Business Corporations Act (Alberta) on March 20, 2014, Yoho and Yoho's direct and indirect wholly-owned subsidiary, Yoho Resources Partnership (the "Partnership" , have disposed of an aggregate of 13,629,442 common shares ("Storm Shares" in the capital of Storm Resources Ltd. ("Storm" . As such, as at the date hereof, neither Yoho nor the Partnership has any ownership or control of any Storm Shares. Pursuant to the Arrangement, each issued and outstanding common share in the capital of Yoho outstanding as at the close of business on March 20, 2014 was exchanged for one new common share in the capital of Yoho and 0.2591 of a Storm Share, which represented a Yoho shareholder's pro rata per share entitlement to an aggregate of 13,629,442 Storm Shares. Prior to the completion of the Arrangement Yoho (indirectly through the Partnership) owned an aggregate of 13,629,442 Storm Shares, representing approximately 12.4% of the outstanding Storm Shares, on a non-diluted basis. The 13,629,442 Storm Shares were initially acquired by Yoho as partial consideration for the sale by Yoho to Storm on January 31, 2014 of Yoho's Montney acreage in the Nig area of Northeast British Columbia.

Yoho Announces Acquisition of Common Shares of Storm Resources
Marketwire - Fri Jan 31, 3:47PM CST
Yoho Resources Inc. ("Yoho" or the "Company" (TSX VENTURE: YO) announces that, in connection with the transaction described below, Yoho's direct and indirect wholly-owned subsidiary, Yoho Resources Partnership (the "Partnership" , acquired ownership and control of 13,629,442 common shares (the "Storm Shares" in the capital of Storm Resources Ltd. (TSX VENTURE: SRX) ("Storm" with a deemed value of $4.25 per share, being the closing price of the Storm Shares on the TSX Venture Exchange ("TSXV" on January 30, 2014 (the trading date immediately prior to the date the Partnership acquired the Strom Shares pursuant to the terms of the Asset Purchase Agreement (as defined below)).

Yoho Resources Inc. Announces Fiscal Q3 Financial Results
Marketwire - Wed Aug 21, 8:03AM CDT
Yoho Resources Inc. (TSX VENTURE: YO) ("Yoho" or the "Company" has filed today on SEDAR the financial statements for the nine months ended June 30, 2013 and the related managements' discussion and analysis ("MD&A" . Copies of these documents may be found on www.sedar.com.

Yoho Resources Inc. Announces Fiscal Q2 Financial Results and Updated Duvernay and Montney Reserves and Contingent Resource Evaluations
Marketwire - Wed May 22, 8:03AM CDT
Yoho Resources Inc. (TSX VENTURE: YO) ("Yoho" or the "Company" has filed today on SEDAR the financial statements for the six months ended March 31, 2013 and the related managements' discussion and analysis ("MD&A" . Copies of these documents may be found on www.sedar.com.

Yoho Resources' Current Production Approaches 3,700 boe Per Day, Acquires Incremental Duvernay Lands at Kaybob and Completes Land Swap at Nig
Marketwire - Wed Apr 03, 8:02AM CDT
Yoho Resources Inc. ("Yoho" or the "Company" (TSX VENTURE: YO) is pleased to provide an update of operations at Kaybob, Alberta and Nig, British Columbia.

Yoho Resources Inc. Announces Fiscal Q1 2013 Financial and Operating Results
Marketwire - Wed Feb 27, 8:03AM CST
Yoho Resources Inc. ("Yoho" or the "Company" (TSX VENTURE: YO) has filed today on SEDAR the financial statements for the three months ended December 31, 2012 and the related managements' discussion and analysis. Copies of these documents may be found on www.sedar.com.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading